ATRA
Atara Biotherapeutics Inc
8.90$
+4.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.3% | +15.4% | -4.4% | -7.5% | -10.6% | +63.2% | -86.9% | -84.7% | +36.1% | -40.8% | -151.7% | – | |
| – | -10.9% | -15.4% | -24.5% | +1.4% | -9.0% | -28.0% | -33.5% | -56.3% | +23.8% | -50.6% | -47.4% | – | |
| – | -469.0% | – | – | – | -441.4% | – | – | – | – | – | – | – | |
| – | -84.3% | +188.6% | -77.2% | -100.0% | – | -100.0% | – | – | – | – | – | – | |
| – | -85.9% | +48.0% | -51.1% | -331.6% | – | +409.4% | -129.5% | -52.2% | – | – | – | – | |
| – | – | -106.4% | – | – | -200.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | +19.3% | +6.4% | -100.0% | – | – | – | – | – | |
| – | – | +1,496.6% | -101.3% | – | -100.9% | -23.8% | – | -93.2% | -100.3% | – | +63.5% | – | |
| – | -306.2% | – | -140.8% | – | -241.5% | – | – | -482.8% | – | -104.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.